ClinicalTrials.gg
TerminatedNCT03409601Updated Mar 18, 2019

The Role of Satiety in the Effect of Portion Size on Intake

An interventional study of 100% Portion Size and 125% Portion Size in Feeding Behavior, sponsored by Penn State University. Terminated at 1 site in United States. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2019-03-18.

Sponsored by Penn State University · Not applicable, Interventional, and Basic science

Why this study was terminated
Additional outcome measures have been developed and added to the protocol.
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Study summary

The study uses a crossover design in which the portion size of food is varied at each meal. Across four test meals, subjects will be served four different portions of food, and intake will be determined from pre- and post-meal food weights. The first visit will be a screening visit, at which subjects will complete the consent form, have their height and weight measured, and rate the taste of the study food. Test meals will be scheduled once a week for four weeks. At visits 2-5, subjects will eat lunch and rate characteristics of the meal. At visit 6, subjects will complete various questionnaires. The objective of this study is to determine whether any individual characteristics related to satiety influence the effect of portion size on intake.

02

Conditions studied

  • Feeding Behavior

Keywords

  • Obesity, eating behavior, food, nutrition
03

In context

Feeding Behavior

985 studies on the registry are indexed under Feeding Behavior; 178 are open to participants now.

This study's enrollment of 14 is below the median of 77 across 700 interventional studies indexed under Feeding Behavior.

Browse Feeding Behavior studies →

Lead sponsor

Penn State University is the lead sponsor of 270 studies on the registry; 53 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 11 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be willing and able to travel to Penn State University Park campus weekly for meals
  • Be a man or woman 18 - 60 years old
  • Regularly eat 3 meals/day
  • Be willing to avoid alcohol the day before and during test days
  • Have a between 18.0 and 35.0 kg/m-squared
  • Be willing to refrain from eating after 10 pm the evening before test sessions

Exclusion criteria

Exclusion Criteria:

  • A smoker
  • An athlete in training
  • Pregnant or breastfeeding at the time of screening
  • Have taken prescription or non-prescription drugs that may affect appetite or food intake within the last 3 months
  • Dislike or be unable to eat the test foods (because of allergies, intolerance, or dietary restrictions)
  • Currently dieting to gain or lose weight
  • Have a health condition that affects appetite
  • Have participated in a similar study in our lab in the past year
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    100% Portion Size

    Test meal consists of baseline (100%) portion size of meal.

    Other: 100% Portion Size

  • Experimental
    125% Portion Size

    Test meal consists of food portion size that is 125% the size of baseline portion.

    Other: 125% Portion Size

  • Experimental
    150% Portion Size

    Test meal consists of food portion size that is 150% the size of baseline portion.

    Other: 150% Portion Size

  • Experimental
    175% Portion Size

    Test meal consists of food portion size that is 175% the size of baseline portion.

    Other: 175% Portion Size

Interventions

  • Other100% Portion Size

    Meal portion size at baseline

  • Other125% Portion Size

    Meal portion size 125% of baseline

  • Other150% Portion Size

    Meal portion size 150% of baseline

  • Other175% Portion Size

    Meal portion size 175% of baseline

06

What researchers measure

Primary outcomes

  1. Differences in energy intake

    Calculated energy intake (kcal) based on weight and energy density of food consumed

    Time frame: Weeks 1, 2, 3, and 4

  2. Differences in intake by weight

    Weights (grams) of all foods consumed

    Time frame: Weeks 1, 2, 3, and 4

Secondary outcomes

  1. Sensory-specific satiety

    Change in taste pleasantness of eaten foods compared to uneaten foods

    Time frame: Weeks 1, 2, 3, and 4

  2. Eating rate

    Assessed from meal duration and number of bites taken

    Time frame: Weeks 1, 2, 3, and 4

  3. Ratings of hunger and satiety

    100-point visual analog scales

    Time frame: Weeks 1, 2, 3, and 4

  4. Ratings of sensory characteristics of the food

    100-point visual analog scales

    Time frame: Weeks 1, 2, 3, and 4

  5. Ratings of meal characteristics

    100-point visual analog scales

    Time frame: Weeks 1, 2, 3, and 4

07

Study locations

1 site
  • The Pennsylvania State University
    University Park, Pennsylvania 16802, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03409601
Responsible party
Barbara J. Rolls (BJR, Penn State University) — Principal investigator
First posted
Jan 24, 2018
Start date
Apr 2, 2018
Primary completion
Dec 14, 2018
Completion
Dec 14, 2018
Last update
Mar 18, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion